Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Visfatin ELISA Kit (AC3426)
Cat.#: ASET-2015
Specifications
Description Human Visfatin ELISA Kit allows for the in vitro quantitative determination of human Visfatin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1276 Rat IRS1 ELISA Kit (AC2687) Quantitative inquiry ASET-1885 Human Neuroligin 3 ELISA Kit (AC3296) Quantitative inquiry ASET-1468 Sheep IL-6 ELISA Kit (AC2879) Quantitative inquiry ASET-1044 Mouse Calretinin ELISA Kit (AC2455) Quantitative inquiry ASET-2533 Human Creatine Kinase B Type ELISA Kit (AC3944) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-2065 Human FLJ39155 ELISA Kit (AC3476) Quantitative inquiry ASET-1169 Human CELSR2 ELISA Kit (AC2580) Quantitative inquiry ASET-1593 Canine Insulin ELISA Kit (AC3004) Quantitative inquiry ASET-1643 Human GALC ELISA Kit (AC3054) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket